CAI vs COST · rev $812.0M vs P/E 55, rev $275.24B
Caris Life Sciences, Inc. Common Stock (CAI) versus Costco Wholesale Corp (COST) — a side-by-side from cached financials, not a winner call.
Caris Life Sciences, Inc. Common Stock (CAI) is a biotechnology company listed on NASDAQ.
Costco Wholesale Corp (COST) is a discount stores company listed on US. It is led by Ron Vachris.
Latest reported CAI revenue for 2025-12-31 was $812.0M. Net income was -$68.1M. Revenue was up 97.0% from 2024-12-31 to 2025-12-31. CAI currently screens at market cap $5.22B.
Latest reported COST revenue for 2025-08-31 was $275.24B. Net income was $8.10B. COST currently screens at market cap $430.32B and trailing P/E 54.9.
CAI currently screens at market cap $5.22B. COST currently screens at market cap $430.32B and trailing P/E 54.9.
Not investment advice. Open the CAI and COST stock pages for the full models.
Not investment advice.